Diana Oltean, APRN
Family · Wichita, KSNPI 1124596887
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,770 and has fallen 91.3% since, to $153 in 2025. Among family clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $26.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$540
- AstraZeneca$455
- AbbVie$421
- Lilly USA, LLC$389
- Idorsia Pharmaceuticals US Inc$212
- Bayer$210
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,732100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $540 |
| AstraZeneca | 9 | $455 |
| AbbVie | 22 | $421 |
| Lilly USA, LLC | 17 | $389 |
| Idorsia Pharmaceuticals US Inc | 2 | $212 |
| Bayer | 2 | $210 |
| Amgen | 11 | $177 |
| Biohaven Pharmaceuticals, Inc. | 8 | $145 |
| Merck | 10 | $137 |
| Madrigal Pharmaceuticals | 1 | $131 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Pulmonx Corporation | 1 | $122 |
| Daiichi Sankyo Inc. | 7 | $103 |
| Amarin Pharma, Inc. | 5 | $95 |
| Johnson & Johnson | 5 | $64 |
| Hartmann USA, Inc. | 2 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $51 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Boehringer Ingelheim | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Surgenex LLC | 1 | $31 |
| Kerecis Limited | 1 | $27 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Solventum Corporation | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Neos Therapeutics, LP | 1 | $12 |
| Collegium Pharmaceutical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$243
- QUVIVIQ$212
- Kerendia$210
- REZDIFFRA$131
- BREZTRI$125
- NUZYRA$125
- FARXIGA$123
- CHARTIS CATHETER$122
- ZEPHYR DELIVERY CATHETER$122
- ZEPHYR ENDOBRONCHIAL VALVE$122
- PULMONX CHARTIS TABLET CONSOLE$122
- AIRSUPRA$121
- MOUNJARO$109
How this compares
$3,746 in reported general payments places this provider in the 90th percentile of 1,579 family providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levocetirizine Dihydrochloride | 11 | $13 |
Paid to pharmacies, not to this prescriber.
Other family in Wichita
- Kayla del RioWichita$147K
- Kelli RiceWichita$114K
- Mary GonzalesWichita$87K
- Mary GarciaWichita$24K
- Jennifer NeelWichita$15K
- Amanda AstWichita$9K
- Jennifer MartinWichita$8K
- Lauren CoteWichita$7K
- Mimi TranWichita$6K
- Kara NabboutWichita$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.